Summary for Sevoflurane

  • Trade Names: Sevorane; Ultane (AbbVie)
  • Indications: Induction and maintenance of general anesthesia
  • Class: Anesthetic; inhalation
  • Half-life: 15–23 hours
  • Clinically important, potentially hazardous interactions with:
    Mivacurium

Please login to view the rest of this drug profile.

Page last updated 05/19/2026

Symbol key

Incidence - Help

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness - Help

Hospitalization possible
Life threatening
Fatal

Warnings in other populations - Help

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top